
Solanezumab May Be First Drug to Attack the Cause of Alzheimer’s
CBS VIDEO + ARTICLE: Excitement and Hope are 2 words not often heard in Alzheimer’s clinical trials, but new results for solanezumab are generating quite

CBS VIDEO + ARTICLE: Excitement and Hope are 2 words not often heard in Alzheimer’s clinical trials, but new results for solanezumab are generating quite

Diabetics get a lot more dementia than the average person. Yet diabetics taking FDA-approved Actos get a lot LESS dementia than the average person – 47% less. That’s about half the rate. Find out more.

VIDEO + ARTICLE: Diagnostic technology is a powerful weapon in the fight against dementia. Find out how a new map of the ageing brain will

A startling new link shows Alzheimer’s in transplant patients is significantly lower, in fact almost absent, when compared to national data from the general population.

Lymphatic systems serve many tasks, including the draining of waste proteins. A unexpected new discovery found it reaches brain cells. Can it be boosted to

VIDEO + ARTICLE: A new epilepsy drug could be used to treat Alzheimer’s patients. Find out about this new experimental approach.

MEDICATION TRIALS: Although Astra Zeneca’s AZD05030 disappointed cancer researchers, it surprisingly blocked the damage caused by Alzheimer’s plaque. Learn about the speed with which this

VIDEO + ARTICLE: For 25 years, researchers tried curing Alzheimer’s by clearing amyloid plaque. While plaque is a problem, is it merely Alzheimer’s cargo, while

VIDEO: “For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading

VIDEO & ARTICLE: CNBC’s Meg Tirrell reports on Biogen’s experimental drug for Alzheimer’s and how the company appears to have exceeded expectations.

They’re not just pills—they’re precision infusions designed to slow Alzheimer’s at its source. See UCLA’s cutting-edge Amyloid Immunotherapy Care Program, and what it feels like to begin treatment with Leqembi (lecanemab) and Kisunla (donanemab).

With what we know today, even high genetic risk can be beaten —new research reveals that the Mediterranean diet may slow memory decline and lower dementia risk, even for those with the APOE4 gene.

Aphasia affects a person’s ability to communicate. It affects language functions, such as speaking, understanding what others say, and naming common objects. Learn its causes, types and a few tips.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


